Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
39.83
+1.58 (4.13%)
At close: Dec 5, 2025, 4:00 PM EST
39.51
-0.32 (-0.80%)
After-hours: Dec 5, 2025, 7:36 PM EST
HRMY Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for HRMY stock have an average target of 51.33, with a low estimate of 36 and a high estimate of 70. The average target predicts an increase of 28.87% from the current stock price of 39.83.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HRMY stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 6 | 6 | 6 | 6 |
| Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 10 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $39 → $46 | Buy | Maintains | $39 → $46 | +15.49% | Dec 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +38.09% | Nov 24, 2025 |
| Needham | Needham | Strong Buy Reiterates $42 | Strong Buy | Reiterates | $42 | +5.45% | Nov 24, 2025 |
| Mizuho | Mizuho | Buy Maintains $36 → $39 | Buy | Maintains | $36 → $39 | -2.08% | Nov 6, 2025 |
| UBS | UBS | Strong Buy Maintains $50 → $43 | Strong Buy | Maintains | $50 → $43 | +7.96% | Oct 15, 2025 |
Financial Forecast
Revenue This Year
862.56M
from 714.73M
Increased by 20.68%
Revenue Next Year
1.00B
from 862.56M
Increased by 15.93%
EPS This Year
3.27
from 2.51
Increased by 30.15%
EPS Next Year
4.13
from 3.27
Increased by 26.33%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 915.0M | 1.1B | ||||
| Avg | 862.6M | 1,000.0M | ||||
| Low | 814.2M | 915.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 28.0% | 27.8% | ||||
| Avg | 20.7% | 15.9% | ||||
| Low | 13.9% | 6.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.86 | 5.29 | |||
| Avg | 3.27 | 4.13 | |||
| Low | 2.24 | 2.13 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 53.9% | 62.0% | |||
| Avg | 30.1% | 26.3% | |||
| Low | -10.6% | -34.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.